ARALIACEAE Panax ginseng  C.A. Mey.

 Synonym

    none ...
 Thai / English name

  • โสม*

[1-2] of 2 article(s) found

 หน้า  1  

[1] EFFECTS OF SUPERFINE GRINDING ON PHYSICOCHEMICAL AND ANTIOXIDANT PROPERTIES OF LYCIUM BARBARUM POLYSACCHARIDES.
MIN ZHANG,FANG WANG,RUI LIU,ET AL.
LWT - FOOD SCIENCE AND TECHNOLOGY 2014 Vol.58(),594-601  $50580 [Full]

Part Used : -
Activity : CYP2C9 INHIBITION
Solvent/Active Compound : BST204
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The inhibitory potency of BST204 and its bioactive ginsenosides, R-Rg3, S-Rg3, R-Rh2 and S-Rh2, was determined using a nine - CYP isozyme cocktail assay in pooled human liver microsomes. Combining nine specific substrates for each CYP in cocktails is particularly useful because it is possible to measure multiple CYP activities in the same microsomal incubation. In brief, the 90-microlitre incubation mixture, including pooled human liver microsomes (final concentration 0.25 mg/mL), 0.1 M phosphate buffer, each P450-selective substrate cocktail set, and test compounds (0-5 micromolars) was pre-incubated for 5 min at 37 degrees celsius.

[2] EVALUATION OF THE IN VITRO/IN VIVO DRUG INTERACTION POTENTIAL OF BST204, A PURIFIED DRY EXTRACT OF GINSENG, AND ITS FOUR BIOACTIVE GINSENOSIDES THROUGH CYTOCHROME P450 INHIBITION/INDUCTION AND UDP-GLUCURONOSYLTRANSFERASE INHIBITION.
YU FEN ZHENG,SOO HYEON BAE,EU JIN CHOI,ET AL.
FOOD CHEM TOXICOL 2014 Vol.68(),117-27  $50850 [Full]

Part Used : -
Activity : CYP2C9 INHIBITION
Solvent/Active Compound : Ginsenoside S-Rg3
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 0-50 micromolar
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Equivocal
Remark : The inhibitory potency of BST204 and its bioactive ginsenosides, R-Rg3, S-Rg3, R-Rh2 and S-Rh2, was determined using a nine-CYP isozyme cocktail assay in pooled human liver microsomes and IC50 values of ginsenoside S-Rg3 in reversible inhibition CYP450 (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4/5) was > 50 micromolar.

Part Used : -
Activity : CYP2C9 INHIBITION
Solvent/Active Compound : Ginsenoside R-Rg3
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 0-50 micromolar
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Equivocal
Remark : The inhibitory potency of BST204 and its bioactive ginsenosides, R-Rg3, S-Rg3, R-Rh2 and S-Rh2, was determined using a nine-CYP isozyme cocktail assay in pooled human liver microsomes and IC50 values of ginsenoside S-Rg3 in reversible inhibition CYP450 (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4/5) was > 50 micromolar.

Part Used : -
Activity : CYP2C9 INHIBITION
Solvent/Active Compound : Ginsenoside R-Rh2
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 0-50 micromolar
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Equivocal
Remark : The inhibitory potency of BST204 and its bioactive ginsenosides, R-Rg3, S-Rg3, R-Rh2 and S-Rh2, was determined using a nine-CYP isozyme cocktail assay in pooled human liver microsomes and IC50 values of ginsenoside S-Rg3 in reversible inhibition CYP450 (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4/5) was > 50 micromolar.

Part Used : -
Activity : CYP2C9 INHIBITION
Solvent/Active Compound : Ginsenoside S-Rh2
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 0-50 micromolar
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Equivocal
Remark : The inhibitory potency of BST204 and its bioactive ginsenosides, R-Rg3, S-Rg3, R-Rh2 and S-Rh2, was determined using a nine-CYP isozyme cocktail assay in pooled human liver microsomes and IC50 values of ginsenoside S-Rg3 in reversible inhibition CYP450 (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4/5) was > 50 micromolar.

Part Used : -
Activity : CYP2C9 INHIBITION
Solvent/Active Compound : BST204 (a purified dry extract of ginseng)
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 0-50 micromolar
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The inhibition potency of BST204 and its bioactive ginsenosides, R-Rg3, S-Rg3, R-Rh2 and S-Rh2, was determined using a nine-CYP isozyme cocktail assay in pooled human liver microsomes and BST204 slightly inhibited CYP2C8, CYP2D6, CYP2C9, and CYP2B6 activities with IC50 values of 17.4, 26.8, 31.5, and 49.7 microgram/mL, respectively.


 หน้า  1